SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.1

943.25

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.06

Back

Jaihind Industries standalone net profit rises 600.00% in the June 2026 quarter

Aug 15,2026

Net profit of Jaihind Industries rose 600.00% to Rs 0.07 crore in the quarter ended June 2026 as against Rs 0.01 crore during the previous quarter ended June 2025. Sales rose 750.00% to Rs 0.17 crore in the quarter ended June 2026 as against Rs 0.02 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.17	0.02	750
OPM %	41.18	50.00	-
PBDT	0.07	0.01	600
PBT	0.07	0.01	600
NP	0.07	0.01	600

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)